Compare ALZN & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALZN | MLEC |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5M | 5.0M |
| IPO Year | 2021 | 2022 |
| Metric | ALZN | MLEC |
|---|---|---|
| Price | $1.14 | $1.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.2K | ★ 76.4K |
| Earning Date | 12-08-2026 | 12-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 76.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.42 |
| Revenue Next Year | N/A | $30.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.84 | $0.21 |
| 52 Week High | $2.68 | $23.22 |
| Indicator | ALZN | MLEC |
|---|---|---|
| Relative Strength Index (RSI) | 27.44 | 19.76 |
| Support Level | $1.04 | N/A |
| Resistance Level | $1.25 | $9.08 |
| Average True Range (ATR) | 0.09 | 0.53 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 6.06 | 6.14 |
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.